Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Cervical Cancer, November 2026

Free Subscription


Abstracts

Retrieve all available abstracts of the following 256 articles:
HTML format


 

Single Articles

  1. GRAY K, McRae K, Kong I, Altas M, et al
    Hormone replacement after radiotherapy for premenopausal patients with cervical cancer: a retrospective cohort study.
    J Obstet Gynaecol Can. 2026 Oct 30:103559. doi: 10.1016/j.jogc.2026.103559.
    PubMed    
    Abstract available

  2. MIMOUN C, Carcopino X, Carcopino X, Ouldamer L, et al
    ASSESSMENT OF TREATMENT RESPONSE RESPONSE AND THE ROLE OF COMPLETION SURGERY AFTER CONCURRENT CRTAND BRACHYTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER - A REVIEW FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP.
    J Gynecol Obstet Hum Reprod. 2026 Oct 30:103311.
    PubMed    
    Abstract available

  3. GOODARZI M, Aghbash PS, Baghi HB
    HPV-associated extracellular vesicles and the tumor microenvironment: mechanisms of immune modulation and translational implications.
    Mol Biol Rep. 2026;53:1857.
    PubMed    
    Abstract available

  4. MO X, Wang H, Wang Z, Xiao Y, et al
    Multifaceted HPV16 E2 as a potential therapeutic target for cervical cancer and beyond.
    Mol Biol Rep. 2026;53:1858.
    PubMed    
    Abstract available

  5. MAITY G, Fahreen S, Banerji A, Choudhury PR, et al
    Correction to: Fibronectin-integrin mediated signaling in human cervical cancer cells (SiHa).
    Mol Cell Biochem. 2026 Oct 30. doi: 10.1007/s11010-026-05769.
    PubMed    


  6. RANA S, Kundu A, Ghosh D, Datta P, et al
    Comparative immunohistochemical analysis of survivin, p53, and Ki-67 expression in cervical squamous intraepithelial lesions and squamous cell carcinoma.
    Indian J Pathol Microbiol. 2026;69:419-424.
    PubMed    
    Abstract available

  7. VERMA RS, Asmita A, Singh V, Kumari R, et al
    Diagnostic and prognostic significance of p16, p53, and PD-L1 expression in cervical lesions: A combined immunohistochemical, histopathological, and radiological correlation study.
    Indian J Pathol Microbiol. 2026;69:413-418.
    PubMed    
    Abstract available

  8. CASTRIGNANO E, Sarcina L, Mongelli V, Iacobellis I, et al
    Biofunctional Molecular Large Surfaces Enabling Ultrasensitive Detection for Early Diagnosis of Cervical Cancer.
    Chem Mater. 2026;38:10515-10524.
    PubMed    
    Abstract available

  9. HARERIMANA A, Mchunu G
    Text, talk, screen: mapping mHealth interventions for cervical cancer prevention and control in Africa - a scoping review.
    Front Digit Health. 2026;8:1947988.
    PubMed    
    Abstract available

  10. ZHANG Z, Dong X, Yu T, Li H, et al
    VAMP5 Mediates Sevoflurane-Induced Immune Modulation in Cervical Cancer: A Clinical Translational Study.
    Anesthesiol Res Pract. 2026;2026:9114246.
    PubMed    
    Abstract available

  11. CHEPKOECH P, Jordan SB, Makhulo B, Ambaka J, et al
    Assessing an educational strategy to improve community health provider-led provision of cervical cancer screening services in western Kenya: A secondary analysis of the Elimisha-HPV cluster-randomized controlled trial.
    Glob Health Med. 2026;8:332-341.
    PubMed    
    Abstract available

  12. CHAVANA A, Flanagan M, Owrangi A, Sharma S, et al
    Real-world experience with INTERLACE-style induction chemotherapy: Tumor regression and MRI-guided brachytherapy in locally advanced cervical cancer.
    Gynecol Oncol Rep. 2026;68:102231.
    PubMed    
    Abstract available

  13. LEGENDRE E, Dutrey-Kaiser A, Attalah Y, Boyer G, et al
    Effectiveness of health mediation to promote organised cancer screening among underserved and under-screened populations in Marseille, France: findings from a repeated cross-sectional survey.
    BMC Public Health. 2026;26:3129.
    PubMed    
    Abstract available

  14. BIARI H, Galeshi M, Yazdani S, Ranaei M, et al
    Cervical cytological abnormalities and human papillomavirus status in HPV-vaccinated and unvaccinated women: a cross-sectional study.
    BMC Womens Health. 2026;26:572.
    PubMed    
    Abstract available

  15. YOKOI A, Machida H, Okazawa-Sakai M, Nishino K, et al
    Correction: Optimal adjuvant strategy in intermediate-risk cervical cancer: a systematic review and meta-analysis.
    Int J Clin Oncol. 2026 Oct 29. doi: 10.1007/s10147-026-03225.
    PubMed    


  16. MOLINA MA, Zhang Y, Steenbergen RDM, Melchers WJG, et al
    Towards a sequential microbiome therapy for HPV-associated cervicovaginal dysbiosis.
    Commun Biol. 2026;9:1422.
    PubMed    
    Abstract available

  17. MATSUMOTO T, Yoshida K, Nakai M, Kawamura Y, et al
    Incidence of Nausea and Vomiting in Patients With Cervical Cancer Undergoing Chemoradiotherapy With Steroid-Sparing.
    In Vivo. 2026;40:3763-3774.
    PubMed    
    Abstract available

  18. CARCOPINO X, Ouldamer L, Huchon C, Leveque J, et al
    FROM EVIDENCE REVIEW TO CLINICAL RECOMMENDATIONS: FRENCH GUIDELINES FOR CERVICAL CANCER MANAGEMENT FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP.
    J Gynecol Obstet Hum Reprod. 2026 Oct 29:103318.
    PubMed    


  19. DUGAST M, Moureau A, Tromelin E, Sousa C, et al
    CERVICAL CANCER IN OLDER WOMEN - A NARRATIVE REVIEW OF AGE-SPECIFIC MANAGEMENT ISSUES FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP.
    J Gynecol Obstet Hum Reprod. 2026 Oct 29:103317.
    PubMed    
    Abstract available

  20. BUFFETEAU A, Chauvet P, Cordoba A, Leveque J, et al
    POST-TREATMENT SURVEILLANCE AND MANAGEMENT OF RECURRENT CERVICAL CANCER - A REVIEW FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP.
    J Gynecol Obstet Hum Reprod. 2026 Oct 29:103315.
    PubMed    
    Abstract available

  21. MAJHI S, Saini R, Kumar R, Sharma DN, et al
    Synchronous presacral schwannoma and carcinoma cervix: A rare diagnostic and therapeutic dilemma.
    J Cancer Res Ther. 2026;22:1011-1015.
    PubMed    
    Abstract available

  22. BAJWA HK, Natte R, Beriwal S, Chaudhari S, et al
    Outcomes of MR interstitial hybrid brachytherapy in Carcinoma Cervix with novel commercial intravaginal template - initial results from an Indian cancer center.
    J Cancer Res Ther. 2026;22:987-992.
    PubMed    
    Abstract available

  23. OZCAN E
    The Relationship Between Attitudes Toward Early Detection of Cervical Cancer, Religious Health Fatalism, and Hope levels in Women: A Cross-Sectional Study in Turkiye.
    J Relig Health. 2026 Oct 28. doi: 10.1007/s10943-026-02817.
    PubMed    
    Abstract available

  24. VERA-PONCE VJ, Ballena-Caicedo J, Garcia-Rodriguez M, Sagastegui Jauregui JD, et al
    Scaling up primary HPV DNA screening and self-sampling for cervical cancer in Peru: Coverage, cost-utility, and budget impact analysis using public data sources.
    J Med Screen. 2026 Oct 29:9691413261494992. doi: 10.1177/09691413261494992.
    PubMed    
    Abstract available

  25. T SF, M R, Packirisamy V, Gopinath SCB, et al
    Gold-molybdenum disulfide functional nanocomposites for cervical cancer therapy: in vitro anticancer activity and modulation of pro-apoptotic markers.
    Prep Biochem Biotechnol. 2026 Oct 29:1-9. doi: 10.1080/10826068.2026.2749457.
    PubMed    
    Abstract available

  26. CARMACK C, Ahmed N, Marinoni A, Ousley T, et al
    Feasibility and proof-of-concept of a cervical cancer prevention edutainment webisode for African American women in Houston, Texas.
    Int J Public Health. 2026;71:1609804.
    PubMed    
    Abstract available

  27. JIANG J, Zhang Y, Wang M, Zhang R, et al
    Exploratory transcriptomic profiling of melittin's efficacy in the treatment of murine cervical cancer cells.
    Front Cell Dev Biol. 2026;14:1975665.
    PubMed    
    Abstract available

  28. SEFUTHI T, Van Schalkwyk C, Nkonki L
    A patient costing analysis of Lesotho's cervical cancer screening program.
    Front Public Health. 2026;14:1888325.
    PubMed    
    Abstract available

  29. YUE W, Tian H, Cai X, Yu B, et al
    IVIM-based habitat imaging for non-invasive assessment of Ki-67 proliferation status in cervical cancer.
    Front Oncol. 2026;16:1885498.
    PubMed    
    Abstract available

  30. YANG ST, Wang PH
    Bevacizumab in cervical cancer: Balancing survival benefit and serious adverse events.
    Taiwan J Obstet Gynecol. 2026;65:1080-1082.
    PubMed    


  31. WANG PH, Morisada T, Kobayashi Y, Tjokroprawiro BA, et al
    The positive association between radiotherapy and subsequent ischemia stroke in the cervical cancer patients is worthy of attention.
    Taiwan J Obstet Gynecol. 2026;65:1070-1072.
    PubMed    


  32. DEVINS KM
    Rhabdomyosarcoma of the Cervix/Vagina and Its Mimics.
    Surg Pathol Clin. 2026;19:637-646.
    PubMed    
    Abstract available

  33. HODGSON A, Park KJ
    An Atlas-Based Approach to Assigning International Federation of Gynecology and Obstetrics Stage to Different Presentations of Cervical Cancer.
    Surg Pathol Clin. 2026;19:553-567.
    PubMed    
    Abstract available

  34. WANG B, Chang Z
    Effect of Solution-focused Outpatient Follow-up on Post-surgery Resilience and Sexual QoL in Cervical Cancer.
    J Low Genit Tract Dis. 2026 Oct 28. doi: 10.1097/LGT.0000000000000988.
    PubMed    
    Abstract available

  35. TIPPAYAWONG R, Kansandee W, Loymunkong C, Sirinantananon P, et al
    Corrigendum to "In vitro and in silico antiviral activity of Polyscias scutellaria leaf extract against drug-susceptible and drug-resistant herpes simplex virus and human papillomavirus-positive cervical cancer: implications for topical formulation de
    Virus Res. 2026 Oct 27:199819. doi: 10.1016/j.virusres.2026.199819.
    PubMed    


  36. UTSUMI N, Kawamura H, Yamano T, Hayakawa T, et al
    Retrospective Study of Pelvic Irradiation in Patients With Advanced Uterine Cervical Cancer.
    Anticancer Res. 2026;46:6175-6182.
    PubMed    
    Abstract available

  37. MAKITA C, Yin L, Kobayashi S, Kajiura Y, et al
    Listeria monocytogenes meningitis after pembrolizumab-based chemoradiotherapy for cervical cancer: A case report.
    J Infect Chemother. 2026;32:103114.
    PubMed    
    Abstract available

  38. MIDHUN TA, Murugesan K
    Vaccination-driven suppression, stochastic variability, and contact saturation in HPV-cervical cancer transmission in India: A Black-Karasinski perturbation model.
    Math Biosci. 2026 Oct 27:109839. doi: 10.1016/j.mbs.2026.109839.
    PubMed    
    Abstract available

  39. CARCOPINO X, Ouldamer L, Huchon C, Asseeva P, et al
    CERVICAL CANCER: NATIONAL CLINICAL PRACTICE GUIDELINES FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP.
    J Gynecol Obstet Hum Reprod. 2026 Oct 27:103314.
    PubMed    
    Abstract available

  40. OULDAMER L, Deberti M, Morineau F, Carcopino X, et al
    Risk-Adapted surgical treatment of early-stage cervical cancer: tailoring radicality, ovarian preservation, and surgical approach in the post-shape and post-lacc era - A review from the french cervical cancer guidelines group.
    J Gynecol Obstet Hum Reprod. 2026 Oct 27:103316.
    PubMed    
    Abstract available

  41. FUSS E, Lecointre L, Gladieff L, Bendifallah S, et al
    Special situations in cervical cancer management: de novo metastatic disease, occult cancer after simple hysterectomy, and cervical stump cancer - A review from the french cervical cancer guidelines group.
    J Gynecol Obstet Hum Reprod. 2026 Oct 27:103312.
    PubMed    
    Abstract available

  42. MARGUERITTE F, Mathevet P, Diguisto C, Carcopino X, et al
    FERTILITY-SPARING SURGERY AND OVARIAN TRANSPOSITION IN CERVICAL CANCER - A REVIEW FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP.
    J Gynecol Obstet Hum Reprod. 2026 Oct 27:103313.
    PubMed    
    Abstract available

  43. MERECZ-SADOWSKA A, Kowalski M, Kowalczyk T, Trzcinski M, et al
    Celastrol and Its Derivatives in Breast, Ovarian, and Cervical Cancer: Molecular Targets, Signalling Networks, and Nanocarrier-Based Delivery.
    Molecules. 2026;31:3641.
    PubMed    
    Abstract available

  44. ZHOU X, Hu J, Zhou R, Lu Y, et al
    The Vaginal Microbiome Across the Continuum from HPV Infection to Cervical Cancer: A Narrative Review.
    Microorganisms. 2026;14:2158.
    PubMed    
    Abstract available

  45. WANG X, Lin N, Cao Y, Vishwakarma J, et al
    Polymer-Based Additive Manufacturing in Cervical Cancer Management: A Review.
    Polymers (Basel). 2026;18:2455.
    PubMed    
    Abstract available

  46. DWORNIK R, Cylwik D, Bialkowska K
    Immune Response Gene Polymorphisms and Cervical Cancer Susceptibility.
    Int J Mol Sci. 2026;27:9384.
    PubMed    
    Abstract available

  47. KORNIENKO TE, Zakharenko AL, Chernyshova IA, Chepanova AA, et al
    Safety and Antitumor Activity of the Usnic Acid Derivative OL9-116, a TDP1 Inhibitor, as an Adjunctive Therapy in Combination with Topotecan.
    Int J Mol Sci. 2026;27:9266.
    PubMed    
    Abstract available

  48. ATES S, Ay A, Coker GB, Gjergjizi N, et al
    Real-World Guideline Concordance and Potential Overtreatment Following Primary Radical Hysterectomy for Early-Stage Cervical Cancer.
    J Clin Med. 2026;15:7952.
    PubMed    
    Abstract available

  49. LOPEZ-GONZALEZ DB, Sertic M, Moskowitz CS, Rasmussen RG, et al
    Uterine Cervical Cancer Treatment and Outcomes Among Medicare-Insured Patients in the United States.
    Healthcare (Basel). 2026;14:3488.
    PubMed    
    Abstract available

  50. CHANG H, Wang X, Wu Y, Li Q, et al
    Engineering Polymeric Biomaterials for Radiation-Induced Vaginal Injury After Cervical Cancer Therapy: Pathobiological Basis, Material Strategies, and Future Perspectives.
    Bioengineering (Basel). 2026;13:1169.
    PubMed    
    Abstract available

  51. FAN Y, Lian CW, Yang XY, Li JK, et al
    Comparison of Survival After Radical Hysterectomy or Radical Radiotherapy Among Patients with Different Histological Types of Locally Advanced Cervical Cancer: Analysis of SEER Data Using Propensity Score Matching.
    Cancers (Basel). 2026;18:3371.
    PubMed    
    Abstract available

  52. KATOH Y, Fujii Y, Yamazaki N, Kubo A, et al
    Serum Free Fatty Acid-Based Diagnostic Index for Cervical Cancer Including High-Risk HPV-Negative Cases: An Independent Validation Study.
    Diagnostics (Basel). 2026;16:3387.
    PubMed    
    Abstract available

  53. SCHICHL K, Doorbar J
    Productive or Transforming? How Epithelial Compartmentalization of HPV DNA and E6/E7 Transcripts Shapes Cervical Screening Assay Performance.
    J Med Virol. 2026;98:e71196.
    PubMed    
    Abstract available

  54. LIU J, Wang J, Gao Y, Cui X, et al
    ELAVL1 overexpression potentiates cervical cancer malignancy via regulating the ACVRL1/CASP14 pathway.
    iScience. 2026;29:117956.
    PubMed    
    Abstract available

  55. HUANG L, Hu Y, Yu Y
    Ultrasound-Responsive Nanoplatforms in HPV-Associated Cervical Cancer: Reprogramming the Post-Infection Microenvironment.
    Int J Nanomedicine. 2026;21:642841.
    PubMed    
    Abstract available

  56. KOSHY E, Son C
    Population-Level Shifts in Cervical Cancer Stage Distribution in the United States Following Human Papillomavirus (HPV) Vaccine Implementation.
    Cureus. 2026;18:e118618.
    PubMed    
    Abstract available

  57. LI H, Ke Y, Wu M, Shen L, et al
    Cervical cancer screening willingness and associated health beliefs among predominantly college-educated young women attending gynecology clinics in Shenzhen, China.
    Front Public Health. 2026;14:1969898.
    PubMed    
    Abstract available

  58. GONG W, Liu X, Wang M, Hu X, et al
    Multi-sequence magnetic resonance imaging radiomics integrated with clinical features predicts pelvic lymph node metastasis in cervical cancer: a retrospective-prospective cohort study.
    Front Med (Lausanne). 2026;13:1910248.
    PubMed    
    Abstract available

  59. CHEN Y, Jiang Y, Wang Q, He Z, et al
    RBM15/IGF2BP1-mediated m(6)A methylation of AKR1B10 promotes the progression of cervical squamous cell carcinoma.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2026;51:1661-1676.
    PubMed    
    Abstract available

  60. OHAKA N, Okere GN, Asuzu NC, Ekenedo GO, et al
    Institutional and Demographic Barriers to Cervical Cancer Screening among Women in Rivers State, Nigeria.
    Asian Pac J Cancer Prev. 2026;27:3809-3815.
    PubMed    
    Abstract available

  61. YIN K, Li Y, Tang M
    LncRNA RASAL2-AS1 serves as a potential biomarker for prognosis and regulates cellular processes via the miR-590-5p/PDCD5 axis and Wnt/beta-catenin pathway in cervical cancer.
    Hereditas. 2026;163:120.
    PubMed    
    Abstract available

  62. ALI ZM, Boutib A, Said KS, Saad ELM, et al
    Health-related quality of life among Djiboutian women with gynecological cancers, predominantly cervical cancer : a cross-sectional analytical study.
    BMC Womens Health. 2026;26:561.
    PubMed    
    Abstract available

  63. HE J, Wang D, Fu M, Wu Y, et al
    Immediate histological risk and one-year outcomes following P16-based triage of HPV-positive women.
    BMC Womens Health. 2026;26:559.
    PubMed    
    Abstract available

  64. DENG Z, Bi X, Zhang H
    A knowledge graph-guided transcriptomic framework identifies a 20-gene prognostic signature for cervical cancer.
    BMC Bioinformatics. 2026;27:248.
    PubMed    
    Abstract available

  65. LIU N, Niu S, Sun X, Xin H, et al
    Dysregulation of the miR-557/MELK axis and its correlation with tumor markers in cervical cancer.
    Lab Med. 2026;57:lmag085.
    PubMed    
    Abstract available

  66. LAHRMANN B, Keil A, Miranda Ruiz F, Clarke MA, et al
    Closing the Automation Gap in HPV-Based Cervical Cancer Screening: Independent External Validation of an AI Model for Dual-Stain Triage.
    NEJM AI. 2026;3:AIoa2600270.
    PubMed    
    Abstract available

  67. FANG C, Liu S, Xia J, Wu X, et al
    Intensity-modulated radiotherapy combined with albumin-bound paclitaxel and platinum-based chemotherapy for locoregional recurrent cervical cancer: a single-institutional phase II investigator-initiated nonrandomized clinical trial.
    J Cancer Res Clin Oncol. 2026;152:204.
    PubMed    
    Abstract available

  68. SCRIPCARIU IS, Matasariu DR, Socolov DG, Anton GI, et al
    Anxiety and Depression in Cervical Cancer Patients in Relation to Nutritional Status and Oxidative Stress.
    Med Sci (Basel). 2026;14:657.
    PubMed    
    Abstract available

  69. CHEN J, Jiang F, Chen X, Lin R, et al
    MRI-Based Radiomics Model for Pretreatment Prediction of Pathological Lymph Node Metastasis in Neuroendocrine Carcinoma of the Cervix: Dual-Center Development and External Validation.
    Curr Oncol. 2026;33:625.
    PubMed    
    Abstract available

  70. LIAO X, Liu Y, Tang Y, Lei Y, et al
    Quality Disparities and Recommendation Consistency of Cervical Cancer Screening Guidelines: A Systematic Appraisal With the AGREE II Instrument.
    J Eval Clin Pract. 2026;32:e70703.
    PubMed    
    Abstract available

  71. MA N, Xu K, Wang Z
    Study on the molecular mechanism of bone marrow mesenchymal stem cells inducing epithelial-mesenchymal transition in HPV-associated cervical cancer through activation of miR-129.
    Pak J Pharm Sci. 2027;40:326-341.
    PubMed    
    Abstract available

  72. MAI Y, Hua H, Liang S, Ye G, et al
    Ubiquitination of parkin influences its tumor suppressive function in cervical cancer.
    Cell Mol Life Sci. 2026;83:395.
    PubMed    
    Abstract available

  73. WINKLER L, Power R, Allison KR, Strnadova I, et al
    The Role of Self-Collection in Optimising Cervical Screening for People With Intellectual Disability: A Multi Perspective Qualitative Study.
    Health Expect. 2026;29:e70920.
    PubMed    
    Abstract available

  74. GASHU C, Tasfa B, Alemu C, Kassa Y, et al
    Retraction Note: Assessing survival time of outpatients with cervical cancer: at the university of Gondar referral hospital using the Bayesian approach.
    BMC Womens Health. 2026;26:553.
    PubMed    


  75. LIU Y, Xi H, Min S, Yang H, et al
    Dioscin Promotes Ferroptosis in Cervical Cancer Cells via the TIGAR-ROS Axis.
    Cancer Sci. 2026 Oct 23:10.1111/cas.70560. doi: 10.1111/cas.70560.
    PubMed    
    Abstract available

  76. CAMPOS CS, Bovo AC, Fonseca B, Santana IV, et al
    Performance of HPV testing and liquid-based cytology after negative colposcopy in women with ASC-H, HSIL or AGC cytology.
    Rev Bras Ginecol Obstet. 2026;48:e-rbgo62.
    PubMed    
    Abstract available

  77. WANG S, Ding J, Chen X, Zhao M, et al
    Non-cancer causes of death following cervical cancer diagnosis: a SEER database study.
    J Gynecol Oncol. 2026 Oct 19. doi: 10.3802/jgo.2027.
    PubMed    
    Abstract available

  78. WANG W, Lin Z, Liu J
    Radical versus simple trachelectomy for fertility preservation in early-stage cervical cancer: a retrospective cohort study based on propensity score inverse probability of treatment weighting.
    J Gynecol Oncol. 2026 Oct 16. doi: 10.3802/jgo.2027.
    PubMed    
    Abstract available

  79. SAAD A, Goldstein J, Atamneh R, Helpman L, et al
    Pelvic Insufficiency Fractures After Chemoradiotherapy for Cervical Cancer: Incidence, Long-Term Outcomes, and Survivorship Management.
    Oncologist. 2026 Oct 23:oyag427. doi: 10.1093.
    PubMed    
    Abstract available


  80. Correction: Trends in cervical cancer incidence and mortality in Mongolia, 2014-2024: a population-based analysis of pandemic-related disruptions.
    Front Oncol. 2026;16:1993185.
    PubMed    
    Abstract available

  81. RESENDIZ-CASTILLO LJ, Martinez-Barajas MG, Carranza-Aranda AS, Garcia-Bernal JR, et al
    Cancer-associated fibroblasts from cervical cancer modulate protumoral neutrophil functions: evidence from a pilot exploratory study.
    Front Immunol. 2026;17:1900567.
    PubMed    
    Abstract available

  82. MCNAIR A, Dau H, Nakisige C, Smith L, et al
    Exploring the Social and Financial Impacts of Cervical Cancer on Caregivers in Low- and Middle-Income Countries: A Scoping Review.
    Psychooncology. 2026;35:e70641.
    PubMed    
    Abstract available

  83. WANG H, Li Y, Zheng J, Wang J, et al
    BRAP maintains SEC24D stability to regulate ER stress and promote cervical adenocarcinoma progression.
    J Transl Med. 2026;24:1331.
    PubMed    
    Abstract available

  84. ZHOU L, Cai Q, Wang X, Li W, et al
    FMCerNet: frequency-aware multi-label learning for fine-grained cervical cytology screening.
    Bioinformatics. 2026;42:btag759.
    PubMed    
    Abstract available

  85. CAJAS-SALAZAR N, Mueses-Moreno LJ, Sierra-Torres CH
    Micronucleus cytome assay reveals genomic instability in premalignant cervical lesions among high-risk HPV-positive women.
    Biotech Histochem. 2026;101:501-512.
    PubMed    
    Abstract available

  86. MCCLYMONT E, Blitz S, Nicolls S, Lee M, et al
    Long-term immunogenicity and efficacy of the quadrivalent human papillomavirus vaccine in women with HIV: a longitudinal cohort study.
    Lancet HIV. 2026;13:e779-e787.
    PubMed    
    Abstract available

  87. TAGAJDID MR, Azelmat S, Goura H, Znady MR, et al
    Human Papillomavirus Genotype Distribution among Adult Women in the Rabat Region (Morocco): A Retrospective and Analytical Study with Implications for HPV Vaccination Strategies.
    Intervirology. 2026;69:34-43.
    PubMed    
    Abstract available

  88. BAKHACHE N, Winkler E, Castelo M, Selk A, et al
    Exploring the Differences in Severity of Cervical Dysplasia between Ontario Residents and Refugees: A Retrospective Cohort Study.
    J Obstet Gynaecol Can. 2026;48:103500.
    PubMed    
    Abstract available

  89. PORTOCARRERO-BONIFAZ A, Parisi A, Viviers E, McLemore LB, et al
    EQD2 In modern cervix HDR brachytherapy: Clinical utility, sources of uncertainty, and interpretation.
    Brachytherapy. 2026;25:981-991.
    PubMed    
    Abstract available

  90. BERGMAN AJ, Daniels-Donkor S, Go S, Datesman AR, et al
    HIV and Human Papilloma Virus Community Service Integration Among Women: A Systematic Review and Narrative Synthesis.
    J Assoc Nurses AIDS Care. 2026;37:e70-e82.
    PubMed    
    Abstract available

  91. ZHANG K
    Mesonephric-like Adenocarcinoma of the Female Genital Tract: A Comprehensive Review of Clinicopathological, Immunophenotypic, Molecular Features, and Clinical Management.
    Int J Surg Pathol. 2026;34:1945-1957.
    PubMed    
    Abstract available

  92. KUMAR N, Kumar RR, Singh A, Vyas A, et al
    Silencing of E6/E7 proteins of HPV-16 in the CaCx cell line upregulate the expression of POTE-Paralogs.
    BMB Rep. 2026;59:466-473.
    PubMed    
    Abstract available

  93. ARORA I, Ganesan R, Sokhi T, Shiomi T, et al
    Cervical HPV-independent adenosquamous carcinoma: report of a case series.
    Virchows Arch. 2026;489:963-972.
    PubMed    
    Abstract available

  94. FATIMA E, Abdul Rehman K, Ur Rehman O, Salih N, et al
    Efficacy and safety of adjuvant chemotherapy for locally advanced cervical carcinoma: an updated Systematic review and meta-analysis.
    J Chemother. 2026;38:603-618.
    PubMed    
    Abstract available

  95. AROH AC, Madujibeya I, Asante Antwi H, Aroh U, et al
    Examining the Role of Social Determinants of Health on Adherence to Pap Screening Guidelines for US Women Aged 21 to 64 Years: Evidence From the 2022 Health Information National Trends Survey.
    Cancer Nurs. 2026;49:e859-e867.
    PubMed    
    Abstract available

  96. SU R, Sun A, Zhao T, Wang H, et al
    Quantitative Proteomics Reveals CBX4 Promotes Cervical Cancer Cell Proliferation by Regulating PFKFB4.
    J Proteome Res. 2026;25:6289-6300.
    PubMed    
    Abstract available

  97. ZHANG J, Ji M, Lv N, Zhou Y, et al
    Cervicovaginal microbiome modulates HPV genotype-specific clearance/persistence: role of bacterial dysbiosis in cervical carcinogenesis.
    Ann Med. 2026;58:2754577.
    PubMed    
    Abstract available

  98. SHI L, Khan MU
    Competing Endogenous Ribonucleic Acid Networks in Cervical Cancer: Mechanisms and Clinical Implications.
    J Vis Exp. 2026;.
    PubMed    
    Abstract available

  99. KAZIMOVA L, Samadzade R, Hanelibeyli M, Hacisoy Y, et al
    [A Multicenter Retrospective Investigation of the Distribution of High-Risk HPV Genotypes Among Women Who Underwent HPV Testing in Azerbaijan].
    Mikrobiyol Bul. 2026;60:467-479.
    PubMed    
    Abstract available

  100. ELIZONDO A, Asare M
    Determinants of female college students' likelihood of accepting self-collected samples for cervical cancer prevention.
    Am J Health Stud. 2026;41:42-51.
    PubMed    
    Abstract available

  101. BAE J, Kim U, Kang S
    Predicting outcomes in locally advanced cervical cancer treated with radiotherapy: a systematic review of nomograms.
    Front Oncol. 2026;16:1940047.
    PubMed    
    Abstract available

  102. XIAO C, Tian F, Kang M, Xie F, et al
    Dose- and time-resolved immune states in cervical cancer radiotherapy: dynamic multimodal biomarkers for adaptive immunoradiotherapy.
    Front Immunol. 2026;17:1981103.
    PubMed    
    Abstract available

  103. GWAYI S, Tomoka T, Chimusa ER, Fedoriw Y, et al
    Utilizing a Variant Prioritization Approach to Explore Genetic Variants in Cervical Cancer Cases among Malawian Women.
    medRxiv [Preprint]. 2026 Oct 26:2026.10.23.26364490.
    PubMed    
    Abstract available

  104. AHMED KS
    Comments with 'Cross-country inequalities and frontier analysis in global burden of cervical cancer: cross-sectional studies'.
    J Gynecol Oncol. 2026 Nov 3. doi: 10.3802/jgo.2026.
    PubMed    


  105. NISAR B, Naseem N
    A comprehensive assessment of cervical cancer risk factors, screening modalities, and cytological outcomes.
    J Pak Med Assoc. 2026;76:1505-1509.
    PubMed    
    Abstract available

  106. LU Y, Wang L, Wang Y, Zhu Z, et al
    From synthesis to clinic: a task-specific framework for CT images metal artifact reduction in cervical brachytherapy.
    Radiat Oncol. 2026;21:152.
    PubMed    
    Abstract available

  107. ZULFEEN M, Howell D, Dogar O
    Barriers to the uptake of cervical cancer screening methods in Low- and Middle-Income Countries (LMICs) - a scoping review using framework thematic analysis.
    BMC Womens Health. 2026;26:589.
    PubMed    
    Abstract available

  108. HAZNEDAR H, Ozsert Yigit G, Haznedar B
    Attentive interpretable tabular learning (TabNet) for miRNA expression classification in cervical cancer and Alzheimer's disease.
    BMC Bioinformatics. 2026;27:264.
    PubMed    
    Abstract available

  109. BARTOSOVA M, Kinkorova Lunackova I, Bouda J, Cerna K, et al
    Methylation test versus dual staining in the triage of HR-HPV positive women - pilot data from cervical cancer screening.
    Ceska Gynekol. 2026;91:357-362.
    PubMed    
    Abstract available


  110. Statement of Retraction: MACC1 regulates the AKT/STAT3 signaling pathway to induce migration, invasion, cancer stemness, and suppress apoptosis in cervical cancer cells.
    Bioengineered. 2026;17:2745772.
    PubMed    


  111. MUSLU A, Kilci Erciyas S
    The Effect of Health Anxiety on Cervical Cancer Attitudes and Beliefs.
    Oncol Nurs Forum. 2026;53:1-13.
    PubMed    
    Abstract available

  112. ZHENG Y, Yi H, Zhu L, Huang J, et al
    Discovery-locked cross-platform evaluation of a cervical epithelial transcriptional state.
    Funct Integr Genomics. 2026;26:321.
    PubMed    
    Abstract available

  113. HARADA M, Hagiwara Y, Kabasawa T, Sato H, et al
    Carcinoma In Situ Skip Lesions of the Uterine Corpus in Cervical Squamous Cell Carcinoma: Impact on Target Setting in Radiotherapy.
    Cancer Rep (Hoboken). 2026;9:e70751.
    PubMed    
    Abstract available

  114. WIJAYANTO FPS, Simanjuntak AMT, Sirait PCNB, Kusnadi AAZ, et al
    PD-1/PD-L1 inhibitors plus chemotherapy in cervical cancer: A systematic review and meta-analysis.
    Turk J Obstet Gynecol. 2026 Nov 5. doi: 10.4274/tjod.galenos.2026.70923.
    PubMed    
    Abstract available

  115. MERRY K, Laheri Z, Johns S, Hirst Y, et al
    Understanding Cervical Screening Engagement Among Young South Asian Women: Perspectives of Women and Healthcare Professionals.
    Health Expect. 2026;29:e70960.
    PubMed    
    Abstract available

  116. ZHANG L, Shen Q, Zhu J, Wang P, et al
    Calycosin Promotes Ferroptosis in Cervical Cancer via the AMPK/PI3K-TFEB-Autophagy-Lysosome Axis.
    J Cell Biochem. 2026;127:e70136.
    PubMed    
    Abstract available

  117. ZHU H, Li J, Liang Y, Li W, et al
    A virtual physicist framework integrating dose prediction and large language models for automated treatment planning.
    J Appl Clin Med Phys. 2026;27:e70904.
    PubMed    
    Abstract available

  118. LIU X, Hua B, Xia Y, Huang H, et al
    Clinical Outcomes and Safety Profile of Camrelizumab Plus Famitinib in Persistent, Recurrent, or Metastatic Cervical Cancer.
    Oncol Res. 2026;34:21.
    PubMed    
    Abstract available

  119. CHEN M, Xiao G, Xiao H, Bai Y, et al
    High-risk factors associated with persistence and progression of cervical intraepithelial neoplasia 2 in women of reproductive age undergoing conservative management: a retrospective analysis.
    Front Public Health. 2026;14:1961644.
    PubMed    
    Abstract available

  120. HWANG H, An T, Seo EH, Park PG, et al
    A novel HPV mRNA vaccine candidate: immunogenicity and definition of immune correlates of protection.
    Front Immunol. 2026;17:1925901.
    PubMed    
    Abstract available

  121. FAN X, Jia Y, Li X, Huang M, et al
    SCG3 and YAP1 define molecular subtypes of small cell carcinoma of the cervix with divergent multi-omics features and prognostic outcomes.
    J Transl Med. 2026;24:1382.
    PubMed    
    Abstract available

  122. SUN J, Xu Y, Guo K, Feng Q, et al
    Identification of prognostic genes associated with innate lymphoid cells in cervical cancer through bioinformatics analyses and experimental assays.
    Infect Agent Cancer. 2026;21:75.
    PubMed    
    Abstract available

  123. YU CL, Lin CL, Lee HL, Chiou HL, et al
    ESM1-mediated DNMT3A suppresses cervical cancer metastasis through epigenetic regulation of ID3 expression.
    Cell Death Discov. 2026;12:438.
    PubMed    
    Abstract available

  124. HUPPE LG, Okechukwu CA, Nanbigne T, Wang G, et al
    Pre-implementation assessment of upstream domains on the uptake of HPV self-sampling in safety-net settings: a scoping review.
    Sex Health. 2026;23:SH25187.
    PubMed    
    Abstract available

  125. KHAMDAMOVA M, Khalilova M, Askarova Z, Yusupova M, et al
    MORPHOLOGICAL FEATURES OF THE CERVICAL EPITHELIUM AND STROMA IN CHRONIC RECURRENT CERVICITIS WITH AND WITHOUT SQUAMOUS INTRAEPITHELIAL LESIONS: A COMPARATIVE CROSS-SECTIONAL STUDY.
    Georgian Med News. 2026;:226-233.
    PubMed    
    Abstract available

  126. SAYED U, Kubaev A, Polatova D, Ali MK, et al
    TWIST family in cervical cancer biology: From molecular mechanisms to clinical implications.
    Exp Cell Res. 2026 Nov 4:115215. doi: 10.1016/j.yexcr.2026.115215.
    PubMed    
    Abstract available

  127. OBODOECHINA N, Smith JS, Kalulu P, Olusanya OA, et al
    Human Papillomavirus Genotypes Among Women With Invasive Cervical Cancer in Nigeria: A Scoping Review.
    JCO Glob Oncol. 2026;12:e2500022.
    PubMed    
    Abstract available

  128. SUN Y, Zhang D, Chen Y, Dai G, et al
    Cucurbitacin I induces pyroptosis via NF-kappaB/TNFR1/caspase-8/caspase-3/GSDME axis for cervical cancer treatment.
    Cell Oncol (Dordr). 2026;49:145.
    PubMed    
    Abstract available

  129. CANDAN E, Ulker Z
    Gossypetin and luteolin, alone and with cisplatin, preferentially reduce MCF-7 breast cancer cell viability, whereas HeLa cervical cancer cells are refractory.
    Mol Biol Rep. 2026;53:1898.
    PubMed    
    Abstract available

  130. CHEN J, Shi Y, Song Y, Liu G, et al
    Deciphering intratumoral heterogeneity: An interpretable radiopathologic framework for lymph node staging in early-stage cervical cancer.
    Med Oncol. 2026;43:369.
    PubMed    
    Abstract available

  131. HOLST CG, Norgaard B, Marcussen M
    Women's Experience of Human Papillomavirus Self-Sampling in Cervical Cancer Screening Programs: A Scoping Review.
    Public Health Nurs. 2026 Nov 4. doi: 10.1111/phn.70203.
    PubMed    
    Abstract available

  132. WANG JY, Chen LJ
    Expression of Concern: The role of miRNAs in the invasion and metastasis of cervical cancer.
    Biosci Rep. 2026;46:BSR20181377.
    PubMed    


  133. YANG H, Ma L, Ma R, Huang D, et al
    Ketone Body Metabolism in Cancer-Associated Fibroblasts and FSTL3 as Prognostic and Therapeutic Determinants of Chemoradiotherapy Response in Cervical Cancer.
    Front Biosci (Landmark Ed). 2026;31:54670.
    PubMed    
    Abstract available

  134. RACI B, Stojkovska S, Hodolli G, Klisarovska V, et al
    NGAL and traditional biomarkers in cervical cancer: a comparative evaluation using random forest.
    Front Oncol. 2026;16:1933456.
    PubMed    
    Abstract available

  135. WEI Z, Wu Y, Li M, Sa S, et al
    Toxicological effects of acetyl tributyl citrate exposure on the progression of uterine fibroids and cervical cancer.
    Ecotoxicol Environ Saf. 2026;326:121014.
    PubMed    
    Abstract available

  136. LUO R, Li M, Ma L, Huang Z, et al
    Efficacy and safety of PD-1/PD-L1 inhibitors plus chemotherapy +/- bevacizumab for recurrent or metastatic cervical cancer: a systematic review and meta-analysis of randomized controlled trials.
    Front Immunol. 2026;17:1972995.
    PubMed    
    Abstract available

  137. DUAN Y, Liu D, Huang Q, Man J, et al
    Case Report: Prolonged survival with short-course triplet induction and dual maintenance in recurrent/metastatic cervical cancer.
    Front Oncol. 2026;16:1961384.
    PubMed    
    Abstract available

  138. TANG L, Zhou Z, Zeng G, Wang J, et al
    LRP8 drives cervical cancer lymph node metastasis by promoting epithelial-mesenchymal transition and VEGF-C secretion.
    Clin Exp Med. 2026;26:365.
    PubMed    
    Abstract available


  139. Global, regional and national burden of cervical cancer in 1990-2023 with forecasts to 2050: a Global Burden of Disease study.
    Nat Med. 2026 Nov 2. doi: 10.1038/s41591-026-04729.
    PubMed    
    Abstract available

  140. BEETCH J, Bittencourt L, Gutierrez R, Lovera DC, et al
    Barriers limiting access to follow-up care after HPV screening for cervical cancer in global settings: A systematic review.
    Epidemiol Rev. 2026 Nov 2:mxag017. doi: 10.1093.
    PubMed    
    Abstract available

  141. WANG R, Liu J
    Baicalein enhances radiosensitivity in cervical cancer by targeting ALOX15 and regulating lipid metabolism.
    Free Radic Res. 2026 Nov 2:1-14. doi: 10.1080/10715762.2026.2756487.
    PubMed    
    Abstract available

  142. GUZMAN CEV, Martinez C, Layman KA, Rosenkranz SJ, et al
    High Risk Latinas Awareness and Interest in Self-collection for HPV Testing to Prevent Cervical Cancer.
    J Health Care Poor Underserved. 2026;37:1389-1397.
    PubMed    
    Abstract available

  143. CHENG T, Niu R, Li X, Gao X, et al
    Evolving Systemic Intensification Strategies Beyond CCRT in Locally Advanced Cervical Cancer.
    Cancer Manag Res. 2026;18:637635.
    PubMed    
    Abstract available

  144. RUKUNDO-AYEH T, McBain RK, Rasmussen PW, Nakisige C, et al
    Optimising a national screen-and-treat cervical cancer strategy in Uganda: a microsimulation cost-effectiveness and budget impact analysis.
    BMJ Public Health. 2026;4:e005684.
    PubMed    
    Abstract available

  145. ZHANG L, Sheng P, Cai D, Zhao Z, et al
    Mechanistic Study of GSDME and CXCL10 in SUV39H1-Mediated Pyroptosis and Immune Suppression in Cervical Cancer.
    Cancer Med. 2026;15:e72468.
    PubMed    
    Abstract available

  146. NASHANDI TN, Downing C
    Cervical cancer awareness among Namibian women: Perspectives of primary healthcare nurses.
    Afr J Reprod Health. 2026;30:31-43.
    PubMed    
    Abstract available

  147. GOSECKA M, Gosecki M, Urbaniak M, Wielgus E, et al
    Dynamic Hydrogel-Mediated Co-Delivery of Clotrimazole and Nifuratel for Safe and Effective In Vivo Cervical Cancer Treatment.
    J Biomed Mater Res B Appl Biomater. 2026;114:e70172.
    PubMed    
    Abstract available

  148. HIROTA Y, Hirata M, Kawakami M, Ozaki A, et al
    [Evaluation of the Educational Effects of Cervical Cancer and HPV Vaccine Education for Junior High School Students].
    Yakugaku Zasshi. 2026;146:959-967.
    PubMed    
    Abstract available

  149. LEE JW, Lim SY
    Effect of Fucoidan on Chemotherapy Efficacy via MAPK Pathway Modulation in Cervical Cancer.
    J Nutr Sci Vitaminol (Tokyo). 2026;72:391-397.
    PubMed    
    Abstract available

  150. EFFAH K, Tekpor E, Wormenor CM, Klutsey GB, et al
    Utilization and outcome estimates of cervical precancer screening and associated factors among female health workers in Ghana: implications for primary screening programs.
    BMC Health Serv Res. 2026;26:1503.
    PubMed    
    Abstract available

  151. CHEN J, Zhang HP, Zhong LL, Yang XW, et al
    [Human papillomavirus-associated cervical adenocarcinoma with yolk sac tumor differentiation: report of a case].
    Zhonghua Bing Li Xue Za Zhi. 2026;55:1094-1097.
    PubMed    


  152. AIHEMAITIJIANG F, Meng X, Yumai A, Muhanmude Y, et al
    ZC3H13 promotes cervical cancer cell proliferation and stemness and reduces cisplatin sensitivity and apoptosis by stabilizing CTHRC1 mRNA in an m(6)A-Dependent manner.
    Gene. 2026 Nov 1:150474. doi: 10.1016/j.gene.2026.150474.
    PubMed    
    Abstract available

  153. YANG F, Yousif M, Okyere SK, Xu J, et al
    Metabolite profiling and antiproliferative activity of endophytic fungus Alternaria alternata Y-13 isolated from Ageratina adenophora against cervical cancer cells.
    Fitoterapia. 2026;195:107531.
    PubMed    
    Abstract available

  154. ZHANG L, Shen Q, Zhu J, Wang P, et al
    Calycosin synergistically promotes ferroptosis in cervical cancer cells by inducing epithelial-mesenchymal transition.
    Oncol Lett. 2026;32:557.
    PubMed    
    Abstract available

  155. CHEN W, Li S, Wang X, Qian M, et al
    USP22 Facilitates Cervical Cancer Progression via Deubiquitinating and Stabilizing IRAK1 to Activate NF-kappaB Signaling.
    FASEB J. 2026;40:e72419.
    PubMed    
    Abstract available

  156. CHEN H, Yang C, Wang H
    Correlation between high-risk Human Papillomavirus (HPV) viral load and cervical lesions across different subtypes, along with the development of a clinical prediction model.
    BMC Womens Health. 2026;26:573.
    PubMed    
    Abstract available

  157. XIA M, Xu H, Ding N, Wang X, et al
    Quercetin, an active component of Qiu's HuaShi decoction, suppresses glycolysis in cervical epithelial cells to reduce HPV infection via modulating the PRKACA/cAMP/PKA/CREB pathway.
    Biochim Biophys Acta Gen Subj. 2026;1870:131004.
    PubMed    
    Abstract available

  158. MASHHADI ABOLGHASEM SHIRAZI M
    NF-kappaB signaling in persistent high-risk cervical HPV infection: Clinical evidence, molecular mechanisms, and translational therapeutic opportunities.
    Int Rev Immunol. 2026;45:430-448.
    PubMed    
    Abstract available

  159. AHMED AA, Abegaz BY, Abdela SG, Abegaz SS, et al
    Uterine Cervical Tuberculosis Mimicking Malignancy: Case Series from Ethiopia.
    Am J Trop Med Hyg. 2026 Sep 22:tpmd250752. doi: 10.4269/ajtmh.25-0752.
    PubMed    
    Abstract available

  160. DECAESTECKER R, Gondry J, Haem T, Vargas J, et al
    CytoHPV: Assessment of the predictive value of cytological analysis in relation to colposcopy-guided histology, before and after use of the primary HPV test.
    J Gynecol Obstet Hum Reprod. 2026;55:103283.
    PubMed    
    Abstract available

  161. KARLSEN E, Langlois J, Boucoiran I, Brophy J, et al
    Rationale and design of a clinical trial of a reduced dosing schedule for the nonavalent human papillomavirus vaccine in women living with HIV: The NOVA-HIV study.
    Contemp Clin Trials. 2026;170:108475.
    PubMed    
    Abstract available

  162. CHABRE M, Mancini J, Maruani J, Carcopino X, et al
    Diagnostic performance of ASC-H cytology for detecting cervical high-grade intraepithelial lesions and cancer.
    J Gynecol Obstet Hum Reprod. 2026;55:103257.
    PubMed    
    Abstract available

  163. BHONDAVE S, Salvi N
    Open Boari Flap Ureteroneocystostomy in a Radiated Pelvis: A Durable Solution for Complex Distal Ureteric Strictures.
    Ann Afr Med. 2026;25.
    PubMed    
    Abstract available

  164. OTA K, Ota Y, Tasaka K, Shiota M, et al
    Clinically Significant Occult Uterine and Cervical Pathology in Women Undergoing Minimally Invasive Sacrocolpopexy With Concomitant Total Hysterectomy: A Retrospective Consecutive Case Series.
    Int Urogynecol J. 2026;37:3553-3560.
    PubMed    
    Abstract available

  165. YUAN M, Zhao X, Hu S, Zhao S, et al
    Thermal ablation versus loop electrosurgical excision procedure and cold knife conization for cervical intraepithelial neoplasia: efficacy and HPV clearance in a 5-year cohort of Chinese women.
    Cancer Biol Med. 2026;23:1477-94.
    PubMed    
    Abstract available

  166. KNUTSEN A, Mikiver R, Redelius K, Uppugunduri S, et al
    Sexual symptoms in relation to curative pelvic radiotherapy in gynecological cancer patients.
    J Cancer Surviv. 2026;20:2148-2158.
    PubMed    
    Abstract available

  167. PATHAK SO, Shah I, Khedekar T, Manohar SM, et al
    ONC201 (Dordaviprone/TIC10) Variably Modulates Autophagy Response in HPV-Positive Cervical Cancer Cell Lines in a CLPP-Independent Manner.
    J Biochem Mol Toxicol. 2026;40:e71179.
    PubMed    
    Abstract available

  168. ZHU D, Wang X, Wu H, Liang D, et al
    Novel cubic arginine catalysts synergize high-dose radiotherapy for enhanced cervical cancer immunotherapy.
    J Nanobiotechnology. 2026;24:1068.
    PubMed    
    Abstract available

  169. MARINO M, Jamieson E, Ezekiel-Herrera D, Holderness H, et al
    Developing and validating predictive models of electronic health record tool adoption in the pre-implementation stage.
    BMC Health Serv Res. 2026;26:1583.
    PubMed    
    Abstract available

  170. MUHIZI E, Dukundane A, Turatsinze S, Dukundane D, et al
    Assessment of financial toxicity among patients treated for cervical cancer in Rwanda, a cross-sectional study.
    BMC Health Serv Res. 2026;26:1606.
    PubMed    
    Abstract available

  171. NIELSEN T, Floridon C, Bennich G, Pedersen BT, et al
    Effect of thermal ablation on persistent HPV infection in Danish women >/= 40 years of age: a quasi-randomized clinical study.
    BMC Womens Health. 2026;26:609.
    PubMed    
    Abstract available

  172. DANG J, Yao Y, Jiang X, Tan X, et al
    Predictive value of (18)F-FDG PET/CT metabolic parameters combined with the HALP score for the prognosis of patients with cervical squamous carcinoma.
    BMC Med Imaging. 2026;26:613.
    PubMed    
    Abstract available

  173. TOPURIDZE M, Shiukashvili N, Todua T, Javashvili G, et al
    Cervical Cancer Screening Uptake and Associated Behavioral Factors Among Female Primary Health Care Providers in Georgia: A Cross-Sectional Study.
    J Cancer Policy. 2026 Nov 12:100831. doi: 10.1016/j.jcpo.2026.100831.
    PubMed    
    Abstract available

  174. CHOPRA S, Hande V, Gupta A, Rai B, et al
    Compliance to National Cancer Grid of India Guidelines for Locally Advanced Cervical Cancer: Results From a Multicentric Observational Cohort in India.
    JCO Glob Oncol. 2026;12:e2600179.
    PubMed    
    Abstract available

  175. LIAO M, Guo Y, Li J, Li W, et al
    HPV knowledge and willingness to vaccinate among unvaccinated female college students: A cross-sectional comparison between a comprehensive university and a health vocational college in Fujian, China.
    Hum Vaccin Immunother. 2026;22:2732838.
    PubMed    
    Abstract available

  176. CHEN J, Wang W, Qi X, Shayilan N, et al
    Design, Synthesis, and Biological Evaluation of Novel Benzimidazole Derivatives as Dual PI3K/HDAC8 Inhibitors with Potent Anti-Cervical Cancer Activity InVivo.
    J Med Chem. 2026;69:25575-25595.
    PubMed    
    Abstract available

  177. YAVUZ OM, Simsek E, Taskum I, Sinaci S, et al
    Association between lesion location and cervical intraepithelial neoplasia.
    Rev Assoc Med Bras (1992). 2026;72:e20261109.
    PubMed    
    Abstract available

  178. PURUT YE, Gercik I, Tutal AD, Kantarci S, et al
    Same margin, different lesion: margin subtype, glandular involvement, and endocervical curettage status as predictors of residual CIN2+ at repeat loop electrosurgical excision procedure: An 11-year retrospective cohort study.
    Rev Assoc Med Bras (1992). 2026;72:e20261101.
    PubMed    
    Abstract available

  179. SHAO D, Gao P, Wang Q, Ma Y, et al
    Advances in platinum-based drug development for cervical cancer therapy.
    Front Pharmacol. 2026;17:1794356.
    PubMed    
    Abstract available

  180. ALQASSIM E, Al-Qahtani AA, Alqassim AY, Al-Qahtani AA, et al
    Sexually transmitted co-infections as biological modifiers of HPV-driven cervical carcinogenesis: a systematic integrative review.
    Front Cell Infect Microbiol. 2026;16:1938728.
    PubMed    
    Abstract available

  181. LIU J, Wen Y, Peng Y, Zhang H, et al
    Case Report: Brain metastasis from cervical cancer treated with multimodal therapy.
    Front Oncol. 2026;16:1929899.
    PubMed    
    Abstract available

  182. PENG MG, Yuan ZY, Liu LX, Lu S, et al
    Dyadic associations between perceived family resilience and fear of disease progression among reproductive-age patients with cervical cancer and their spouses: a cross-sectional study.
    Front Oncol. 2026;16:1927068.
    PubMed    
    Abstract available

  183. YI H, Han Y, Wang X, Li Q, et al
    METTL1-mediated tRNA m7G methylome remodeling drives macrophage M2 polarization and paclitaxel resistance in cervical cancer.
    Epigenomics. 2026;18:1219-1232.
    PubMed    
    Abstract available

  184. NGO DQ, Ha TK, Tran MNT, Nguyen AMT, et al
    Concordance of flow cytometric E6/E7 mRNA detection with human papillomavirus DNA testing and cervical cytology in a cervical cancer screening cohort.
    J Pathol Transl Med. 2026 Nov 10. doi: 10.4132/jptm.2026.
    PubMed    
    Abstract available

  185. CHEUYEM FZL, Achangwa C, Tchamani R, Tsapi AT, et al
    Human papillomavirus vaccine acceptability in Cameroon: a systematic review and meta-analysis.
    BMC Infect Dis. 2026;26:1985.
    PubMed    
    Abstract available

  186. XU N, Jin L, Li B, Zhang Y, et al
    Prevalence and genotype distribution of human papillomavirus infections among women undergoing HPV testing during 2019-2024 in Xi'an, China.
    BMC Infect Dis. 2026;26:1981.
    PubMed    
    Abstract available

  187. SUN W, Zhang B, Wang Y
    Exploring a potential link between protein kinase C zeta and gut microbiota in cervical cancer: a hypothesis-generating study.
    AMB Express. 2026;16:112.
    PubMed    
    Abstract available

  188. BARRAUD S, Lecompte L, Loison R, Cyrille S, et al
    Integrative genomic and transcriptomic profiles from a prospective cervical cancer study.
    NPJ Precis Oncol. 2026;10:437.
    PubMed    
    Abstract available

  189. KIM SN, Shim SH, Bae J, Kim JH, et al
    Cervicography for cervical cancer screening: A systematic review and meta-analysis.
    Medicine (Baltimore). 2026;105:e51370.
    PubMed    
    Abstract available

  190. GERCHOW L, Baez P, Rodriguez K, Garza Zuazua M, et al
    Preimplementation Factors for a Mobile Decision Support Tool for Cervical Cancer Screening Among Dominican Women Living With HIV: Qualitative Study.
    J Assoc Nurses AIDS Care. 2026 Nov 11. doi: 10.1097/JNC.0000000000000716.
    PubMed    
    Abstract available

  191. KIM J, Kim JH, Kim Y, Lee R, et al
    Long-term follow-up results of topical imiquimod for high-grade cervical intraepithelial neoplasia in young women: an original research.
    BMC Womens Health. 2026;26:603.
    PubMed    
    Abstract available

  192. PENG P, Goh JC, Domingo EJ, Kim JH, et al
    Real-World Treatment Patterns and Unmet Needs of Patients with Locally Advanced Cervical Cancer in Mainland China.
    Oncol Ther. 2026 Nov 10. doi: 10.1007/s40487-026-00472.
    PubMed    
    Abstract available

  193. HE F, Li Y, Zu S, Huang S, et al
    AKR1C2 promotes lymph node metastasis in cervical cancer via a non-canonical nuclear function.
    Cell Death Discov. 2026;12:450.
    PubMed    
    Abstract available

  194. ALAAYEDI M, Kadhim ZM, Ashoor JA, Saeed AM, et al
    Formulation and characterization of lipophilic chemotherapy as ethosomal gel for cervical cancer.
    Wiad Lek. 2026;79:2186-2193.
    PubMed    
    Abstract available

  195. PHOLDAENG K, Lekphrom R, Schevenels FT, Senawong G, et al
    Anticancer activity of polycarpol from Uvaria siamensis roots against human cervical cancer cells in nude mouse xenograft models.
    Res Pharm Sci. 2026;21:824-837.
    PubMed    
    Abstract available

  196. GARBER SE, Pierre-Romain L
    Cervical Cancer Screening: Analyzing Recent Guideline Changes Against Current Trends of Human Papillomavirus (HPV) Risk Factors.
    Cureus. 2026;18:e117745.
    PubMed    
    Abstract available

  197. AGHAJANI S, Vousooghi N, Hajifathali A, Seyhoun I, et al
    Combination Therapy of Cisplatin and Naturally Induced Exosomes from Treated HeLa Cells: A Novel Drug-Free Strategy for Cervical Cancer Treatment.
    Adv Pharm Bull. 2026;16:507-523.
    PubMed    
    Abstract available

  198. RUAN Y, Li Y, Wu D, Han J, et al
    Overall treatment time and oncologic outcomes after definitive radiotherapy or chemoradiotherapy for cervical cancer: a systematic review and meta-analysis.
    Front Oncol. 2026;16:1969525.
    PubMed    
    Abstract available

  199. ZHOU Y, Qamar A, Sulaiman M, Umar M, et al
    Susceptibility of genes PAX8, PBX2, and TERT variants in cervical cancer patients.
    Int J Biol Markers. 2026;41:3936155261433187.
    PubMed    
    Abstract available

  200. WANG Q, Zhang D, Li S, Sun J, et al
    Assessing the feasibility of uTPS for volumetric modulated arc therapy treatment plan optimization of dual-layer multileaf collimator linear accelerators.
    Radiat Oncol. 2026;21:156.
    PubMed    
    Abstract available

  201. HUANG CY, Shih YW, Ho CH, Chiu SF, et al
    Trichomonas vaginalis-shaped inflammatory microenvironment drives macrophage immune signaling and modulates cervical cancer cell proliferation and migration.
    Parasit Vectors. 2026;19:483.
    PubMed    
    Abstract available

  202. HE C, Wang Z, Liu Z, Su X, et al
    A novel deep learning segmentation and multimodal radiomics approach for radiation proctitis prediction in cervical cancer.
    Radiat Oncol. 2026;21:155.
    PubMed    
    Abstract available

  203. KURODA K, Ito K
    Postoperative Bladder Rehabilitation After Radical Hysterectomy for Cervical Cancer: A Systematic Review.
    J Obstet Gynaecol Res. 2026;52:e70541.
    PubMed    
    Abstract available

  204. ALDUR MANJAPPA A, Chadha J, Guru V, Prakash U, et al
    Placental Site Trophoblastic Tumor Presenting as Cervical Pregnancy: A Rare Case Report.
    J Obstet Gynaecol Res. 2026;52:e70557.
    PubMed    
    Abstract available

  205. ZHAO H, Kuai L, Zhang Z, Zhao W, et al
    HPV16 E6 promotes the proliferation of cervical cancer cells through the CPT1A/c-Myc positive feedback loop.
    Acta Biochim Biophys Sin (Shanghai). 2026 Nov 9. doi: 10.3724/abbs.2026195.
    PubMed    


  206. HATHAWAY CL, Klein S, Guha A, Umutesi G, et al
    Potential impact of the United States President's Emergency Plan for AIDS Relief funding cuts on the HIV and cervical cancer burden in Kenya.
    AIDS. 2026 Nov 6. doi: 10.1097/QAD.0000000000004640.
    PubMed    
    Abstract available

  207. BEREZA K, Kukielka A, Trojnarska D, Grabarek BO, et al
    Molecular Determinants of Treatment Resistance in Cervical Cancer: A Systematic Review and Integrative Bioinformatic Analysis of Publicly Available Datasets.
    Med Sci Monit. 2026;32:e953607.
    PubMed    
    Abstract available

  208. ALESHIRE M, Tinman JS, Combs R, Huffines R, et al
    A Community Engaged Feasibility Study of High-Risk Human Papillomavirus Self-Sampling for Cervical Cancer Screening in Sexual and Gender Minority People.
    Fam Community Health. 2026 Nov 9. doi: 10.1097/FCH.0000000000000469.
    PubMed    
    Abstract available

  209. ZHANG J, Yan C, Xu Y, Liu C, et al
    The deubiquitinase PSMD14 accelerates cervical cancer progression, with thiolutin offering a novel therapeutic approach.
    Biol Direct. 2026;21:231.
    PubMed    
    Abstract available

  210. ZHANG C, Cui Y, Yin Y, Wang H, et al
    Early identification of atypical lobular endocervical glandular hyperplasia: a case series.
    J Med Case Rep. 2026;20:700.
    PubMed    
    Abstract available

  211. MHLUNGU S, Steinberg M, Sebitloane M, Ngcobo M, et al
    Cannabis sativa and the endocannabinoid system in cervical cancer: molecular targets and mechanistic insights from preclinical models-narrative review.
    J Cannabis Res. 2026;8:119.
    PubMed    
    Abstract available

  212. DASSI L, Tornesello AL, Vincenzi M, Leone M, et al
    Development of a cell-penetrating peptide for intracellular delivery of a biologically active HPV E6 inhibitor in cervical cancer cells.
    J Exp Clin Cancer Res. 2026;45:233.
    PubMed    
    Abstract available

  213. NTEZIYAREMYE JG, Akandwanaho D, Adong LL
    Rare Sites of Metastases to the Breast and Integumentary System in Advanced Cervical Cancer at Initial Presentation in Eastern Uganda: A Case Report.
    Int Med Case Rep J. 2026;19:650965.
    PubMed    
    Abstract available

  214. DU X, Li H, Zhang G
    Clinicopathologic features and prognosis of human papillomavirus-negative cervical cancer: a single-center analysis of 33 cases.
    Transl Cancer Res. 2026;15:777.
    PubMed    
    Abstract available

  215. ABUZOOR A, Jabin MSR, Jonker C
    Health beliefs and parental responses to human papillomavirus vaccination in the Middle East: a theory-informed narrative synthesis guided by the health belief model.
    Front Public Health. 2026;14:1853938.
    PubMed    
    Abstract available

  216. HABEEB S, Sankarapandian C, Alharbi J, Alshammari F, et al
    Alignment with ambition: knowledge, attitude, and perceived preparedness of undergraduate nursing and paramedical students towards WHO 90-70-90 cervical cancer elimination targets: a comparative study.
    BMC Nurs. 2026;25:1081.
    PubMed    
    Abstract available

  217. RUSSO L, Pintican R, Woitek R, Cunha TM, et al
    ESOI-ESUR multicentre validation of a structured MRI report for cervical cancer staging.
    Eur Radiol. 2026 Nov 6. doi: 10.1007/s00330-026-13022.
    PubMed    
    Abstract available

  218. MAEMOTO H, Toita T, Nishie A
    Radiotherapy for Cervical Cancer: Technical Advances, Clinical Applications, and Future Perspectives.
    J Obstet Gynaecol Res. 2026;52:e70555.
    PubMed    
    Abstract available

  219. SHELLY M, Brun A, Villamil F, Cruchet R, et al
    Co-screening for cervical cancer and other sexually transmitted infections offered to women far from health facilities: a pilot intervention with female sex workers in Paris, France and Yerevan, Armenia.
    Sex Transm Infect. 2026 Nov 6:sextrans-2025-056785.
    PubMed    


  220. ZHANG Q, Li X, Wang Q, Lin Z, et al
    Prognostic impact of positive peritoneal washing cytology in surgically treated cervical cancer.
    Medicine (Baltimore). 2026;105:e51356.
    PubMed    
    Abstract available

  221. LI F, Bao C, Liu Y, Liu B, et al
    Nucleotide metabolism and cervical cancer: A comprehensive study of molecular subtypes and therapeutic targets.
    Medicine (Baltimore). 2026;105:e51463.
    PubMed    
    Abstract available

  222. HE Y, Xie T, Zhou F, Gong Y, et al
    NFYA-transcriptionally activated MTHFD2 promotes cervical cancer progression by inducing mitochondrial dysfunction via AMT.
    Mol Immunol. 2026;200:56-72.
    PubMed    
    Abstract available

  223. OLORUNFEMI T, Rashid S, Khashayar P
    A Multilingual AI-Driven Conversational System for Cervical Cancer Awareness and Risk Assessment: Development and Evaluation Study.
    JMIR Cancer. 2026;12:e103866.
    PubMed    
    Abstract available

  224. ELBERMAWI A, Zulfiqar F, Khan IA, Ali Z, et al
    Phytochemical and biological investigation of Galium sinaicum: Cytotoxic constituents with in vitro PARP-1 inhibitory activity.
    Fitoterapia. 2026;195:107529.
    PubMed    
    Abstract available

  225. CHEN L, Huang Y, Wang D, Lin W, et al
    Integrative multi-omics and Mendelian randomization analysis reveals immune-epigenetic crosstalk potentially involved in cervical carcinogenesis.
    Free Radic Biol Med. 2026;257:1-21.
    PubMed    
    Abstract available

  226. NEFF M, Powell A, Kafle K, Beltran C, et al
    Evaluating the Sociocultural Barriers Impacting Cervical and Breast Cancer Screening Among Nepali and Bhutanese Women in the Dallas-Fort Worth Metroplex.
    J Community Health. 2026;51:957-964.
    PubMed    
    Abstract available

  227. HATHAWAY CL, Tran J, van Schalkwyk C, Kuhn L, et al
    Health economic impact and cost threshold for switching from bivalent to nonavalent HPV vaccination for preadolescent girls in KwaZulu Natal, South Africa: A mathematical modeling analysis accounting for the HIV epidemic.
    J Acquir Immune Defic Syndr. 2026 Jul 21. doi: 10.1097/QAI.0000000000003936.
    PubMed    
    Abstract available

  228. FLYNN K, Saunders T, Hyatt A, Bavor C, et al
    Optimising opportunities for self-collection to improve cervical screening access for people with physical disability in Australia: a qualitative study of service provider perspectives.
    BMC Public Health. 2026;26:3314.
    PubMed    
    Abstract available

  229. LI Y, Jing X, Liu J, Feng S, et al
    HPV16E7-specific affitoxin induces GSDME-mediated pyroptosis via a caspase-3-independent pathway.
    Int J Antimicrob Agents. 2026;67:107911.
    PubMed    
    Abstract available

  230. WANG J, Song L
    China's Integration of HPV Vaccine into National Immunization Program: Current Challenges and Future Path.
    J Cancer Educ. 2026;41:1035-1036.
    PubMed    
    Abstract available

  231. ELLIS LB, Bowden SJ, Tighe J, Arbyn M, et al
    Response to letter Re: Diagnostic testing accuracy of DNA methylation tests for detection of high-grade cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysis.
    Eur J Cancer. 2026;249:117779.
    PubMed    


  232. RIESE C, Yi-Tung Chen E, Nilsson H, Salehi S, et al
    Corrigendum to "Incidence, prevalence, mortality and survival trends in women with endometrial-, ovarian- and cervical cancer in the Nordic countries (1980-2023) with focus on younger women (0-49 years old)". [Gynecol. Oncol. 212 (2026) 152-159].
    Gynecol Oncol. 2026;215:41.
    PubMed    


  233. HOLT HK, Ma W, Gordon HS, Sun J, et al
    Trends in utilization of cervical cancer screening and screening-associated services in a multi-organizational research network in Chicago, Illinois, US.
    Gynecol Oncol. 2026;214:173-181.
    PubMed    
    Abstract available

  234. FAROLFI A, Casadei C, Strada I, Petracci E, et al
    Human papillomavirus vaccination following cervical intraepithelial neoplasia and subsequent cervical cancer: A retrospective propensity score-matched cohort study.
    Gynecol Oncol. 2026;215:52-57.
    PubMed    
    Abstract available

  235. YEN TT, Hsieh TYJ, Lee GY, Melamed A, et al
    Time to treatment initiation in cervical cancer in the United States: Trends by treatment modality and factors associated with delay.
    Gynecol Oncol. 2026;215:154-163.
    PubMed    
    Abstract available

  236. MELAMED A, Covens AL, Pfaendler KS, Nakayama J, et al
    Surgical management of cervical cancer: A Society of Gynecologic Oncology evidence-based review.
    Gynecol Oncol. 2026;215:124-132.
    PubMed    
    Abstract available

  237. CORTEZ CA, Taffe BD, Ellis C, Albright BB, et al
    Barriers to treatment for patients diagnosed with cervical cancer: A systematic review.
    Gynecol Oncol. 2026;215:136-145.
    PubMed    
    Abstract available

  238. SHAO H, Zhao Y, Cui T, Wang T, et al
    Prophylactic extended-field irradiation versus pelvic radiotherapy in high-risk locally advanced cervical cancer with radiologically negative para-aortic lymph nodes: a retrospective cohort study.
    Gynecol Oncol. 2026;215:116-123.
    PubMed    
    Abstract available

  239. SNYMAN LC, Visser C, Dreyer GJ, Lukhwareni A, et al
    Comparison of self-sampling versus clinician-sampling HPV DNA cervical cancer screening in South African women living with and without HIV.
    Int J Gynaecol Obstet. 2026 Oct 29. doi: 10.1002/ijgo.71469.
    PubMed    
    Abstract available

  240. DUBE DL, Debele R, Yilma D
    Determinants of non-utilization of cryotherapy among cervical cancer screening-positive women in public health facilities of West Shoa Zone, Oromia, Ethiopia: An unmatched case-control study.
    Int J Gynaecol Obstet. 2026 Nov 11. doi: 10.1002/ijgo.71490.
    PubMed    
    Abstract available

  241. MELLO GRAZIANO L, Nogueira-Rodrigues A
    Building a common language for cervical cancer clinical trials.
    Int J Gynecol Cancer. 2026 Aug 22:104991. doi: 10.1016/j.ijgc.2026.104991.
    PubMed    


  242. CARUSO G, Casaccia Giordano F, Zanagnolo V, Aloisi A, et al
    International expert consensus on the contemporary role of pelvic exenteration in recurrent or persistent cervical cancer.
    Int J Gynecol Cancer. 2026;36:105629.
    PubMed    
    Abstract available

  243. VIVEROS-CARRENO D, Beshar I, Mora-Soto N, Cruz C, et al
    Follow-up after fertility-sparing surgery for cervical cancer: should human papillomavirus testing be used routinely? A narrative review.
    Int J Gynecol Cancer. 2026;36:104716.
    PubMed    
    Abstract available

  244. PARRA S, Aniyozova D, Phoolcharoen N, Ismail-Pratt I, et al
    Implementation of a national cervical cancer prevention program in Uzbekistan.
    Int J Gynecol Cancer. 2026 Oct 6:105652. doi: 10.1016/j.ijgc.2026.105652.
    PubMed    


  245. CORRIELUS M, Hummel K, Valesano AL, Cheng J, et al
    Artificial intelligence-assisted triage of cervical biopsies using the low-cost, 3D-printed OpenFlexure Microscope: a paired comparative feasibility study.
    Int J Gynecol Cancer. 2026;36:104993.
    PubMed    
    Abstract available

  246. HAGEN KK, Eyjolfsdottir B, Dahl GF, Wang Y, et al
    Early post-operative complications after fertility-sparing surgery for cervical carcinoma: a retrospective study of a centralized national cohort of 127 consecutive women.
    Int J Gynecol Cancer. 2026;36:104986.
    PubMed    
    Abstract available

  247. HANDE V, Ndarukwa S, Rubio AP, Berger D, et al
    Implementing Image-Guided Brachytherapy (IGBT) For Cervical Cancer in Resource-Limited Settings: An International Multicentric Cross-Sectional Study of Resource and Workflow Impact.
    Int J Radiat Oncol Biol Phys. 2026 Oct 30:S0360-3016(26)04396.
    PubMed    
    Abstract available

  248. MENARD J, Lusque A, Attal J, Carrie T, et al
    Impact of sexological follow-up on the sexual function of patients treated with chemo-radiotherapy and brachytherapy for locally advanced cervical cancer: results of the prospective FEMINICOL study.
    Radiother Oncol. 2026 Nov 5:111861. doi: 10.1016/j.radonc.2026.111861.
    PubMed    
    Abstract available

  249. HASSAN N, Ullah A, Khan NU, Jan Z, et al
    Integrative genomic and biophysics analysis of MAPK1 rs1057519911 in cervical cancer: genetic association and therapeutic implications.
    BMC Cancer. 2026;26:1349.
    PubMed    
    Abstract available

  250. VICTOR A, Pedro SX, Barcellos Filho F, da Silva AMC, et al
    Machine learning for risk stratification of in-hospital mortality in patients with cervical cancer: an analysis of hospital admissions in Mato Grosso, Brazil.
    BMC Cancer. 2026;26:1410.
    PubMed    
    Abstract available

  251. WANG R, Hong Y, Huang X, Pan J, et al
    A clinico-radiomic nomogram for preoperative prediction of guideline-defined indications for postoperative adjuvant therapy in early-stage cervical cancer.
    BMC Cancer. 2026;26:1409.
    PubMed    
    Abstract available

  252. XIE Q, Wei J, Zhang Y, Zhang M, et al
    Integrated proteomics of FFPE tissues reveals that upregulation of GALNT2 and SEC24A across cervical disease stages correlates with aggressive phenotype and poor prognosis.
    BMC Cancer. 2026;26:1388.
    PubMed    
    Abstract available

  253. LANGHE R, AlKhatib A, Saber A, Saqr D, et al
    Cultural and structural barriers to HPV vaccine acceptance among young women in the United Arab Emirates.
    PLoS One. 2026;21:e0346507.
    PubMed    
    Abstract available

  254. BLYTHE R, Graves N, Iyer NG, Peres MA, et al
    Age-specific income losses due to HPV-attributable cancers in Singapore.
    PLoS One. 2026;21:e0361921.
    PubMed    
    Abstract available

  255. ASSEFA KT, Worku AG, Muche AA, Geremew BM, et al
    Enablers and barriers to human papillomavirus vaccination implementation among key stakeholders in Ethiopia: A qualitative study.
    PLoS One. 2026;21:e0361925.
    PubMed    
    Abstract available

  256. LAWLEY KA, Kusuma K, Farquhar SA, Goodreau SM, et al
    Prevalence of human papillomavirus and HPV vaccination among cisgender bisexual women: Protocol for a systematic review and meta-analysis.
    PLoS One. 2026;21:e0360427.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum


;